sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> cancer biomarkers market

report

Cancer Biomarkers Market, by Types (Lung, Breast, Cervical, Prostate, Colorectal), Biomarker Types (Genetic, Protein), Applications (Diagnostics, Prognostics, Drug Discovery, Risk Management) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC180 November 2016 100+ FREE 10% CUSTOMIZATION

A biomarker may be a molecule secreted by a tumor or a quick response of the body to the presence of cancer. Biomarkers can be found in body fluids, or tissues that is a sign of normal or abnormal processes. The genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are responsible for cancer diagnosis, prognosis and epidemiology. Biomarkers can differentiate an affected patient from a healthy one. Cancer researchers are focusing on proteomics research with an intention to develop new biomarkers. This feature is creating newer growth opportunities for the cancer biomarkers market. This report studies the current and future aspects of the cancer biomarkers market.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cancer biomarkers market. The scope of this report covers the cancer biomarkers market by its major segments, which include types, biomarker types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Information about the technological advancements influencing the growth of the global market
  • Extensive analysis of the key players dominating the competitive landscape of this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The growth in the incidences of cancer is one of the primary drivers for the cancer biomarkers market.
  • Furthermore, the rising healthcare spending across the world has expanded and improved the access to quality healthcare, which is driving the global market.
  • The increasing demand for personalized medicines for cancer treatments will aid the growth of the cancer biomarkers market.
  • On the other hand, the requirement of huge investments in research, validation of new cancer biomarkers, stringent regulatory norms, and inadequate reimbursement policies may restrain the market growth.

The global cancer biomarkers market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). Although the North America region holds the highest market share and continues to dominate the global cancer biomarkers market, the Asia Pacific region is growing at a faster pace because of rise in number of cancer cases in countries like India, China and Japan. The government in these countries is also investing heavily in R&D studies and creating awareness about cancer, its early diagnosis, and treatment among people, which is boosting the market growth in this region. North America region remains dominant because of availability of well-established healthcare facilities and sufficient funding from the government for medical and healthcare purposes. 

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s cancer biomarkers market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the cancer biomarkers market by the following segments:

  • Cancer Biomarkers Market, by Types
    • Lung Cancer
    • Breast Cancer
    • Cervical Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Other Types
  • Cancer Biomarkers Market, by Biomarker Types
    • Genetic Biomarker
    • Protein Biomarker
  • Cancer Biomarkers Market, by Applications
    • Diagnostics
    • Prognostics
    • Drug Discovery
    • Risk Management
    • Other Applications

KEY MARKET PLAYERS

Key players in the cancer biomarkers market include:

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • Becton, Dickinson and Company
  • Hologic, Inc.       
  • Ambrilia Biopharma Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Cancer Biomarkers Market

TRENDING RELATED REPORT

Biosimilars Market, by Product Types (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Applications (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
  5. CANCER BIOMARKERS MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Lung Cancer
      2. Breast Cancer
      3. Cervical Cancer
      4. Prostate Cancer
      5. Colorectal Cancer
      6. Other Types
  6. CANCER BIOMARKERS MARKET, BY BIOMARKER TYPES
    1. Segment Share
    2. By Biomarker Types
      1. Genetic Biomarker
      2. Protein Biomarker
  7. CANCER BIOMARKERS MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Diagnostics
      2. Prognostics
      3. Drug Discovery
      4. Risk Management
      5. Other Applications
  8. CANCER BIOMARKERS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Biomarker Types
      4. By Applications
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Biomarker Types
      4. By Applications
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Biomarker Types
      4. By Applications
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Types
      3. By Biomarker Types
      4. By Applications
  9. COMPETITIVE LANDSCAPE
  10. KEY MARKET PLAYERS
    1. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. F.Hoffmann-La Roche AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Agilent Technologies
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Thermo Fisher Scientific Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Illumina, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Merck & Co. Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. QIAGEN
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Becton, Dickinson, and Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Hologic, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us